methylprednisolone has been researched along with baricitinib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balci, S; de Jesus, AA; Ekinci, RMK; Goldbach-Mansky, R; Yilmaz, M | 1 |
| Arevalo-Serrano, J; Garcia-Gomez, C; Jimenez-Vizuete, JM; Martinez-Alfaro, E; Rodriguez-Garcia, JL; Sanchez-Nievas, G | 1 |
| Deng, W; Huang, Z; Li, T; Wang, Y; Yi, G; Zheng, S | 1 |
| Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES | 1 |
1 review(s) available for methylprednisolone and baricitinib
| Article | Year |
|---|---|
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2 | 2023 |
3 other study(ies) available for methylprednisolone and baricitinib
| Article | Year |
|---|---|
Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.
Topics: Anti-Inflammatory Agents; Azetidines; C-Reactive Protein; Fever; Gain of Function Mutation; Humans; Infant; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Male; Membrane Proteins; Methylprednisolone; Mutation; Nitriles; Purines; Pyrazoles; Pyrimidines; Skin Diseases; Skin Ulcer; Sulfonamides; Syndrome; Treatment Failure; Turkey; Vascular Diseases | 2020 |
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
Topics: Aged; Antiviral Agents; Azetidines; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Female; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Interferon beta-1b; Janus Kinase Inhibitors; Lopinavir; Lung; Male; Methylprednisolone; Middle Aged; Oximetry; Oxygen Inhalation Therapy; Prospective Studies; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sulfonamides | 2021 |
Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Topics: Adult; Azetidines; Female; Humans; Macrophage Activation Syndrome; Methylprednisolone; Panniculitis; Purines; Pyrazoles; Skin Neoplasms; Sulfonamides; Young Adult | 2022 |